The Research Associate is responsible for supporting preclinical and clinical-stage research programs focused on fibrotic and inflammatory diseases.
Alentis Therapeutics, the Claudin-1 Company, is on a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies.
